Literature DB >> 31589475

Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review.

Kristen Pogreba-Brown1, Erika Austhof1, Alexandra Armstrong1, Kenzie Schaefer1, Lorenzo Villa Zapata1, D Jean McClelland2, Michael B Batz3, Maria Kuecken3, Mark Riddle4, Chad K Porter4, Michael C Bazaco3.   

Abstract

To strengthen the burden estimates for chronic sequelae of foodborne illness, we conducted a scoping review of the current literature for common foodborne pathogens and their associated sequelae. We aim to describe the current literature and gaps in knowledge of chronic sequelae associated with common foodborne illnesses. A comprehensive search was conducted in PubMed, EMBASE, and Web of Science for peer-reviewed articles published January 1, 2000 to April 1, 2018. Articles available in English, of any epidemiological study design, for 10 common foodborne pathogens (Campylobacter, Salmonella, Escherichia coli, Listeria, Shigella, Cryptosporidium, Cyclospora, Giardia, Yersinia, and norovirus) and their associated gastrointestinal (GI)- and joint-related sequelae were included. Of the 6348 titles screened for inclusion, 380 articles underwent full-text review; of those 380, 129 were included for data extraction. Of the bacterial pathogens included in the search terms, the most commonly reported were Salmonella (n = 104) and Campylobacter (n = 99); E. coli (n = 55), Shigella (n = 49), Yersinia (n = 49), and Listeria (n = 15) all had fewer results. Norovirus was the only virus included in our search, with 28 article that reported mostly GI-related sequelae and reactive arthritis (ReA) reported once. For parasitic diseases, Giardia (n = 26) and Cryptosporidium (n = 18) had the most articles, and no results were found for Cyclospora. The most commonly reported GI outcomes were irritable bowel syndrome (IBS; n = 119) and inflammatory bowel disease (n = 29), and ReA (n = 122) or "joint pain" (n = 19) for joint-related sequelae. Salmonella and Campylobacter were most often associated with a variety of outcomes, with ReA (n = 34 and n = 27) and IBS (n = 17 and n = 20) reported most often. This scoping review shows there are still a relatively small number of studies being conducted to understand specific pathogen/outcome relationships. It also shows where important gaps in the impact of chronic sequelae from common foodborne illnesses still exist and where more focused research would best be implemented.

Entities:  

Keywords:  autoimmune disorders; foodborne diseases/complications; foodborne diseases/epidemiology; foodborne infections; functional gastrointestinal disorders; scoping review

Mesh:

Substances:

Year:  2019        PMID: 31589475      PMCID: PMC9246095          DOI: 10.1089/fpd.2019.2692

Source DB:  PubMed          Journal:  Foodborne Pathog Dis        ISSN: 1535-3141            Impact factor:   3.788


  176 in total

1.  Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter.

Authors:  J Schwille-Kiuntke; P Enck; C Zendler; M Krieg; A V Polster; S Klosterhalfen; I B Autenrieth; S Zipfel; J-S Frick
Journal:  Neurogastroenterol Motil       Date:  2011-08-30       Impact factor: 3.598

2.  Joint symptoms after a faecal culture positive Campylobacter infection associated with a waterborne gastroenteritis outbreak: a questionnaire study.

Authors:  T Uotila; M Korpela; R Vuento; J Laine; J Lumio; M Kuusi; M J Virtanen; J Mustonen; J Antonen
Journal:  Scand J Rheumatol       Date:  2014-09-10       Impact factor: 3.641

3.  Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

Authors:  Fermín Mearin; Marc Pérez-Oliveras; Antonia Perelló; Jaume Vinyet; Anabel Ibañez; Jordi Coderch; Mónica Perona
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

4.  Prognostic factors associated with mortality in patients with septic arthritis: a descriptive cohort study.

Authors:  R A Andreasen; N S Andersen; S A Just; R Christensen; Imj Hansen
Journal:  Scand J Rheumatol       Date:  2016-06-16       Impact factor: 3.641

5.  Postinfectious gastrointestinal disorders following norovirus outbreaks.

Authors:  Chad K Porter; Dennis J Faix; Danny Shiau; Jennifer Espiritu; Benjamin J Espinosa; Mark S Riddle
Journal:  Clin Infect Dis       Date:  2012-06-19       Impact factor: 9.079

6.  Postinfectious irritable bowel syndrome--a meta-analysis.

Authors:  Heather A Halvorson; Carey D Schlett; Mark S Riddle
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

Review 7.  The impact of socioeconomic status on foodborne illness in high-income countries: a systematic review.

Authors:  K L Newman; J S Leon; P A Rebolledo; E Scallan
Journal:  Epidemiol Infect       Date:  2015-01-20       Impact factor: 2.451

8.  Health sequelae of human cryptosporidiosis in immunocompetent patients.

Authors:  Paul R Hunter; Sara Hughes; Sarah Woodhouse; Nicholas Raj; Qutub Syed; Rachel M Chalmers; Neville Q Verlander; John Goodacre
Journal:  Clin Infect Dis       Date:  2004-08-02       Impact factor: 9.079

Review 9.  Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome.

Authors:  M Thabane; D T Kottachchi; J K Marshall
Journal:  Aliment Pharmacol Ther       Date:  2007-08-15       Impact factor: 8.171

Review 10.  Serotonin, inflammation, and IBS: fitting the jigsaw together?

Authors:  Robin Spiller
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-12       Impact factor: 2.839

View more
  4 in total

1.  The Role of Yersinia enterocolitica O:3 Lipopolysaccharide in Collagen-Induced Arthritis.

Authors:  Katarzyna Kasperkiewicz; Anna S Świerzko; Marta Przybyła; Janusz Szemraj; Jarosław Barski; Mikael Skurnik; Andrzej Kałużyński; Maciej Cedzyński
Journal:  J Immunol Res       Date:  2020-11-12       Impact factor: 4.818

Review 2.  Yersiniosis in New Zealand.

Authors:  Lucia Rivas; Hugo Strydom; Shevaun Paine; Jing Wang; Jackie Wright
Journal:  Pathogens       Date:  2021-02-10

Review 3.  Use-case scenarios for an anti-Cryptosporidium therapeutic.

Authors:  Paul G Ashigbie; Susan Shepherd; Kevin L Steiner; Beatrice Amadi; Natasha Aziz; Ujjini H Manjunatha; Jonathan M Spector; Thierry T Diagana; Paul Kelly
Journal:  PLoS Negl Trop Dis       Date:  2021-03-11

4.  Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.

Authors:  Erika Austhof; Melanie L Bell; Mark S Riddle; Collin Catalfamo; Caitlyn McFadden; Kerry Cooper; Elaine Scallan Walter; Elizabeth Jacobs; Kristen Pogreba-Brown
Journal:  Epidemiol Infect       Date:  2022-07-08       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.